Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

139.12
+0.49500.36%
Volume:1.19M
Turnover:166.33M
Market Cap:265.43B
PE:21.03
High:141.46
Open:140.58
Low:138.74
Close:138.62
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:0.72
T/O Rate:0.06%
Dividend:4.67
Dividend Rate:3.35%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:6.39
PE(LYR):19.46

Loading ...

Novartis Halts ALS Drug Development After Phase 2 Trial Miss

MT Newswires Live
·
1 hour ago

Novartis AG Rises Wednesday

Dow Jones
·
1 hour ago

Novartis to End ALS Trial Amid String of Study Failures

Dow Jones
·
Yesterday

Legend Biotech Taps Novartis Veteran Zhang as CEO

Reuters
·
Sep 15

NYSE Order Imbalance 99880.0 Shares on Sell Side

THOMSON REUTERS
·
Sep 15

Novartis AG Rises Monday, Outperforms Market

Dow Jones
·
Sep 15

Movement Alert|Novartis AG Rises 3.19% in Regular Trading, Major Shareholder Pushes for Board Overhaul as Analysts Upgrade Rating

Market Focus
·
Sep 14

Movement Alert|Novartis AG Rises 3.04% in Pre-Market Trading, Major Shareholder Pushes for Board Overhaul as Brokerages Upgrade Ratings

Market Focus
·
Sep 14

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

Novartis: More Pain on the Way?

Dow Jones
·
Sep 12

Novartis AG Falls Friday, Underperforms Market

Dow Jones
·
Sep 12

Novartis Needs to Make Progress on Pipeline to Justify Valuation

Dow Jones
·
Sep 11

Novartis shareholder calls for board changes, Reuters reports

TIPRANKS
·
Sep 10

Market Chatter: Novartis Shareholder Urges Board Changes After Trial Failures

MT Newswires Live
·
Sep 10

Novartis India Hits Record High After Recent Acquisition, Distribution Deal

Reuters
·
Sep 10

Novartis AG Falls Wednesday, Outperforms Market

Dow Jones
·
Sep 10

Dyne Therapeutics Myotonic Dystrophy Approach Remains Differentiated, RBC Says

MT Newswires Live
·
Sep 09

Novartis Shouldn't Rush to Cover Upcoming Patent Expirations

Dow Jones
·
Sep 09

RBC Initiates Novartis at Sector Perform With CHF120 Price Target

MT Newswires Live
·
Sep 09

Novartis's Stock Selloff Looks Overdone

Dow Jones
·
Sep 09